Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-08-04 4:41 pm Sale | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Cambrian BioPharma Inc | 3,653,120 14.6% | -1,582,836 (-30.23%) | View |
| 2023-02-14 11:36 am Purchase | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Cambrian BioPharma Inc | 5,235,956 17% | 4,468 (+0.09%) | View |
| 2023-02-13 5:16 pm Purchase | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Peyer James | 5,235,956 17% | 545,803 (+11.64%) | View |
| 2022-06-10 2:18 pm Purchase | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Cambrian BioPharma Inc | 5,231,488 17.1% | 5,231,488 (New Position) | View |